(19)
(11) EP 1 536 825 A1

(12)

(43) Date of publication:
08.06.2005 Bulletin 2005/23

(21) Application number: 02753441.1

(22) Date of filing: 07.08.2002
(51) International Patent Classification (IPC)7A61K 38/21, A61K 39/395, A61K 39/00, C07K 1/00, C07K 16/00
(86) International application number:
PCT/US2002/025154
(87) International publication number:
WO 2004/022088 (18.03.2004 Gazette 2004/12)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI

(71) Applicant: Tanox, Inc.
Houston, TX 77081-2225 (US)

(72) Inventors:
  • CHANG, Tse, Wen
    Taipei, Taiwan (TW)
  • YU, Liming
    La Jolla, CA 92037 (US)

(74) Representative: Adams, Harvey Vaughan John et al
Mathys & Squire,120 Holborn
London EC1N 2SQ
London EC1N 2SQ (GB)

   


(54) INTERFERON AND IMMUNOGLOBULIN FC FRAGMENT HYBRID